As of Tuesday, February 24, Mass General Brigham's hospital campuses and off-site facilities are fully open and operational, with the exception of some limited closures and delays. For real-time updates and service changes, please check our Alerts page.

Kidney Disease Clinical Trials

Abatacept in Treatment Resistant Nephrotic Syndrome

BWH is now enrolling patients with Nephrotic Syndrome in this clinical trial. Call the Kidney-NExT Clinic at 617-732-6383 to enroll.

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children Over the Age of 6 With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD). Read more about the study.

Kidney Disease Clinical Trials

Abatacept in Treatment Resistant Nephrotic Syndrome

Center for Kidney Disease and Novel Experimental Therapeutics (Kidney-NExT)